Compare LACTOSE INDIA with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA AUROBINDO PHARMA LACTOSE INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 459.7 10.9 4,205.1% View Chart
P/BV x 2.4 1.4 163.7% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 LACTOSE INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
AUROBINDO PHARMA
Mar-21
LACTOSE INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs421,023 4.1%   
Low Rs16333 4.8%   
Sales per share (Unadj.) Rs30.6422.8 7.2%  
Earnings per share (Unadj.) Rs-2.292.0 -2.4%  
Cash flow per share (Unadj.) Rs1.6110.0 1.5%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs30.1374.3 8.1%  
Shares outstanding (eoy) m11.44585.94 2.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.6 58.9%   
Avg P/E ratio x-13.37.4 -180.8%  
P/CF ratio (eoy) x17.66.2 284.8%  
Price / Book Value ratio x1.01.8 52.8%  
Dividend payout %04.3 0.0%   
Avg Mkt Cap Rs m330397,398 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m10635,350 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m350247,746 0.1%  
Other income Rs m33,809 0.1%   
Total revenues Rs m353251,555 0.1%   
Gross profit Rs m6281,480 0.1%  
Depreciation Rs m4410,554 0.4%   
Interest Rs m54745 7.3%   
Profit before tax Rs m-3373,990 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-820,098 -0.0%   
Profit after tax Rs m-2553,892 -0.0%  
Gross profit margin %17.832.9 54.1%  
Effective tax rate %24.227.2 89.3%   
Net profit margin %-7.121.8 -32.6%  
BALANCE SHEET DATA
Current assets Rs m197198,235 0.1%   
Current liabilities Rs m116106,652 0.1%   
Net working cap to sales %23.137.0 62.5%  
Current ratio x1.71.9 91.2%  
Inventory Days Days5919 307.8%  
Debtors Days Days67152 1,300.3%  
Net fixed assets Rs m686135,778 0.5%   
Share capital Rs m114586 19.5%   
"Free" reserves Rs m230218,713 0.1%   
Net worth Rs m345219,299 0.2%   
Long term debt Rs m3931,684 23.3%   
Total assets Rs m883334,013 0.3%  
Interest coverage x0.4100.3 0.4%   
Debt to equity ratio x1.10 14,827.5%  
Sales to assets ratio x0.40.7 53.4%   
Return on assets %3.416.4 20.6%  
Return on equity %-7.224.6 -29.2%  
Return on capital %3.033.8 8.7%  
Exports to sales %053.8 0.0%   
Imports to sales %7.416.4 45.2%   
Exports (fob) Rs mNA133,248 0.0%   
Imports (cif) Rs m2640,615 0.1%   
Fx inflow Rs m25133,248 0.0%   
Fx outflow Rs m2744,946 0.1%   
Net fx Rs m-288,302 -0.0%   
CASH FLOW
From Operations Rs m2233,289 0.1%  
From Investments Rs m-625,987 -1.0%  
From Financial Activity Rs m45-13,648 -0.3%  
Net Cashflow Rs m525,831 0.0%  

Share Holding

Indian Promoters % 53.8 48.8 110.3%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 0.6 38.3 1.6%  
FIIs % 0.0 20.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.2 48.2 95.9%  
Shareholders   15,832 338,639 4.7%  
Pledged promoter(s) holding % 39.1 14.9 261.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   CIPLA    LUPIN    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 1,000 Points; ONGC, Coal India & ITC Surge(01:30 pm)

Share markets in India have extended early gains and are presently trading on a strong note.

Related Views on News

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


May 17, 2022 11:17 AM

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA 5-YR ANALYSIS

COMPARE LACTOSE INDIA WITH

MARKET STATS